Michael N. Needle - Concepedia

Author

Michael N. Needle

Children's Hospital of Philadelphia ORCID

Also Known As

M N Needle, M Needle, M. N. Needle, M. Needle, M.N. Needle, MICHAEL N. NEEDLE, Michael N Needle, Michael N. Needle, Michael Needle

Publications

Citations

H-Index

Concepts

All Affiliations

Children's Hospital of Philadelphia University of Pennsylvania Hospital of the University of Pennsylvania Memorial Sloan Kettering Cancer Center Children's National

About

Michael N. Needle is an author at Children's Hospital of Philadelphia specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.4K
2	Pathology	6	6	494
3	Health Sciences	5	5	265
4	Neurology	4	4	424
5	Biomedical Engineering	1	1	95

Michael N. Needle

Publications

6.6K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor Leonard B. Saltz, Neal J. Meropol, Patrick J. Loehrer, Journal of Clinical Oncology	2004	1.7K
Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas R. J. Packer, Jeffrey C. Allen, Peter C. Phillips∥, Journal of neurosurgery	1997	632
A randomized comparison of nativeEscherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study Vassilios I. Avramis, Susan Sencer, Antonia Periclou, Blood	2002	490
Cetuximab, a Monoclonal Antibody Targeting the Epidermal Growth Factor Receptor, in Combination With Gemcitabine for Advanced Pancreatic Cancer: A Multicenter Phase II Trial Henry Q. Xiong, Arthur Rosenberg, Albert F. LoBuglio, Journal of Clinical Oncology	2004	481
Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm David G. Pfister, Yungpo Bernard Su, Dennis H. Kraus, Journal of Clinical Oncology	2006	298
Chemoreduction and Local Ophthalmic Therapy for Intraocular Retinoblastoma Debra L. Friedman, Bruce P. Himelstein, Carol L. Shields, Journal of Clinical Oncology	2000	268
Prognostic signs in the surgical management of plexiform neurofibroma: The Children’s Hospital of Philadelphia experience, 1974-1994 Michael N. Needle, Avital Cnaan, James Dattilo, The Journal of Pediatrics Neuro-oncologyPlexiform NeurofibromaPediatric NeurosurgeryMedicineSurgical Pathology	1997	257
Tivozanib versus sorafenib in patients with advanced renal cell carcinoma (TIVO-3): a phase 3, multicentre, randomised, controlled, open-label study Brian I. Rini, Sumanta K. Pal, Bernard Escudier, The Lancet Oncology UrologyGenitourinary CancerTivozanib Versus SorafenibMedicineImmune Checkpoint Inhibitor	2019	248
Multicenter Phase I/II Study of Cetuximab With Paclitaxel and Carboplatin in Untreated Patients With Stage IV Non–Small-Cell Lung Cancer Christiane D. Thienelt, Paul A. Bunn, Nasser H. Hanna, Journal of Clinical Oncology	2005	204
Combined Chemoreduction and Adjuvant Treatment for Intraocular Retinoblastoma Carol L. Shields, Jerry A. Shields, Michael N. Needle, Ophthalmology Surgical OncologyOcular DiseaseOphthalmologyMedicineAdjuvant Treatment	1997	191

Page 1